NCT03277339View on ClinicalTrials.gov

Psycho-biological Substrates of Therapeutic Benefit of Thermal Cure on Generalized Anxiety Disorders

PHASE4CompletedINTERVENTIONAL
Enrollment

52

Participants

Timeline

Start Date

January 19, 2017

Primary Completion Date

January 8, 2020

Study Completion Date

February 5, 2020

Conditions
Generalized Anxious Disorders
Interventions
DRUG

Paroxetine

Deroxat® (20 mg/day) 3 week; can be increase on week 2 until 50 mg.

OTHER

Thermal cure

Thermal cure is realized for 3 weeks

Trial Locations (2)

17600

Les thermes de Saujon, Saujon

Unknown

Centre Hospitalier Henri Laborit, Poitiers

All Listed Sponsors
collaborator

Association Francaise pour la Recherche Thermale

OTHER

collaborator

Les thermes de Saujon

UNKNOWN

collaborator

Poitiers University Hospital

OTHER

collaborator

Centre National de la Recherche Scientifique (CeRCA, umr 7295), France

UNKNOWN

lead

Centre Hospitalier Henri Laborit

OTHER

NCT03277339 - Psycho-biological Substrates of Therapeutic Benefit of Thermal Cure on Generalized Anxiety Disorders | Biotech Hunter | Biotech Hunter